Julius Chembo

Program: Cancer Biology

Current advisor: Ben Major, PhD

Undergraduate university: LeMoyne-Owen College, 2018

Enrollment year: 2020

Research summary
Discovering and validating pharmacological/ therapeutic inhibitors of NRF2 in Lung, Head and Neck Cancers

Graduate publications
Paiboonrungruang C, Xiong Z, Lamson D, Li Y, Bowman B, Chembo J, Huang C, Li J, Livingston EW, Frank JE, Chen V, Li Y, Weissman B, Yuan H, Williams KP, Ben Major M, Chen X. 2023 Small molecule screen identifies pyrimethamine as an inhibitor of NRF2-driven esophageal hyperplasia. Redox Biol, 67():102901. PMCID: PMC10558795